<?xml version='1.0' encoding='utf-8'?>
<document id="27387538"><sentence text="Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6." /><sentence text="A significant number of new chemical entities (NCEs) fail in drug discovery due to inhibition of Cytochrome P450 (CYP) enzymes" /><sentence text=" Therefore, to avert costly drug failure at the clinical phase it becomes indispensable to evaluate the CYP inhibition profile of NCEs early in drug discovery" /><sentence text=" In light of these concerns, we envisioned to investigate the inhibitory effects of S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide], a novel and potent antithrombotic agent, on nine major CYP enzymes (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4) of human liver microsomes (HLM)"><entity charOffset="84-170" id="DDI-PubMed.27387538.s4.e0" text="S002-333 [2-(4-methoxy-benzenesulfonyl)-2,3,4,9-tetrahydro-1H-b-carboxylic acid amide]" /></sentence><sentence text=" S002-333 exists as racemic mixture of S004-1032 (R-isomer) and S007-1558 (S-isomer), consequently, we further examined the enantioselective differences of S002-333 in the inhibition of human CYP enzymes" /><sentence text=" Of the CYP enzymes tested, CYP2B6-catalyzed bupropion 6-hydroxylation was inhibited by S002-333 (IC50 ∼ 9"><entity charOffset="45-54" id="DDI-PubMed.27387538.s6.e0" text="bupropion" /></sentence><sentence text="25 ± 2" /><sentence text="46 μM) in a stereoselective manner with (S)-isomer showing potent inhibition (IC50 ∼ 5" /><sentence text="28 ± 1" /><sentence text="25 μM) in contrast to (R)-isomer which showed negligible inhibition on CYP2B6 activity (IC50 &gt; 50 μM)" /><sentence text=" S002-333 and its (S)-isomer inhibited CYP2B6 activity in a non-competitive fashion with estimated Ki values of 10" /><sentence text="1 ± 3" /><sentence text="4 μM and 5" /><sentence text="09 ± 1" /><sentence text="05 μM, respectively" /><sentence text=" No shift in the IC50 value was observed for S002-333 and its isomers when preincubated for 30 min in the presence of NADPH suggesting that neither S002-333 nor its enantiomers are time-dependent inhibitors"><entity charOffset="118-123" id="DDI-PubMed.27387538.s16.e0" text="NADPH" /></sentence><sentence text=" Thus, the present findings signified that S002-333 is a potent stereoselective inhibitor of CYP2B6, whereas, inhibition for other CYPs was substantially negligible" /><sentence text=" These in vitro findings would be useful in deciding the development of S002-333 as a single-enantiomer or as a racemic mixture" /><sentence text=" " /></document>